Non-Vascular Stents Market Analysis
Non-vascular Stents Market, by Product Type (Urological Stents, Gastrointestinal Stents, Pulmonary Or Airway Stents, Others) and by Region - Global Trends, and Forecast to 2025
Non-vascular Stents Market – Minimally Invasive Management of a Wide Variety of Circulatory Disorders
Non-vascular stents are a family of devices used for a variety of applications, including esophageal, biliary, colonic, tracheal, and bronchial implantations. Non-vascular stents employs minimally-invasive procedure for implantation. A minimally-invasive procedure offers faster recovery with reduced pain, and shorter hospital stay. Non-vascular stents are increasingly being used in various applications such as in the treatment of pulmonary, urological, and gastrointestinal diseases. The use of these stents is also increasing in the neural and ophthalmic fields.
The global non-vascular stents market was valued at US$ 934.7 million in 2017 and is expected to witness a robust CAGR of 4.7% over the forecast period (2017 - 2025).
Figure 1. Global Non-vascular Stents Market (US$ Mn), by Region, 2017
To have a snippet of the report, request Report Sample
Increasing demand for minimally invasive procedures is expected to boost market growth
Increasing demand for minimally invasive procedures is expected to be a major factor driving the growth of the global non-vascular stents market. Non-vascular stents involve small accurate incisions, resulting in relatively smaller and lesser noticeable scars incurred by conventional surgical procedures that compromise on patient safety. Such a procedure is associated with faster recovery time, thus reducing a patient’s hospital stay. Furthermore, reduced hospital stay in turn, is expected to lower the risk of contracting hospital-acquired infections such as bloodstream infection, urinary tract infection, etc. among patients. These factors pose as major drivers boosting growth of the non-vascular stents market.
Increasing prevalence of chronic diseases is expected to drive market growth
Increasing prevalence of gastrointestinal, urological and pulmonary or airway diseases is expected to fuel the demand for non-vascular stents. Conditions such as chronic obstructive pulmonary disease (COPD), central airway obstruction, and asthma demand the use of pulmonary stents, to open up narrowed airways and ease the respiration process. According to WHO, more than three million people die each year from COPDs worldwide and 90% of these deaths in low and middle income countries. Furthermore, in U.S., every year, kidney disorders kills more people than prostate or breast cancer. For instance, in 2013, approximately 47,000 Americans died from kidney disease. Gastrointestinal diseases have been a major problem and cover a wide variety of parts of the system, (i.e. rectum, intestines, duodenum, and esophagus). Generally, these diseases are treated with palliation with the use of non-vascular stents. In recent years, non-vascular stents have been a standard treatment for removing occluding tumors in the gastrointestinal system.
Advancements in technology to accelerate the market growth
Increasing advancements in technology and material is aiding in the development of specially designed stents for used in various indications, is increasing the demand for non-vascular stents in a wide range of applications. For instance, the development of biodegradable polymers and bio-absorbable scaffolds is increasing the use of stents in pulmonary, gastrointestinal, urological, and biliary strictures. Poly capro-lactone, poly acryl amine, and poly lactic acid-glycolic acid are few of the newly designed biodegradable stent materials, which eliminate the need for stent removal. Nitinol is increasingly being utilized in non-vascular self-expandable stents, as it offers super elasticity and therefore is beneficial to the stent placement in difficult segments of an internal tract. However, high costs of non-vascular stents is expected to negatively impact growth of the market.
Major players operating in the global non-vascular stents market include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, S.R.O, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena.
Non-vascular stents are mainly shielded with a polymeric film or membrane to avoid ingrowth of adjacent tissues through stent mesh. Drugs for suppression of hyperplastic malignant or benign tissues can be integrated into polymeric materials. Materials widely used in stent covering include polyurethane, silicon, and expanded polytrafluoroethylene (e-PTFE). Stents in non-vascular applications are a standard treatment for removal of occluding tumors in the gastrointestinal system.
Major factor driving growth of the non-vascular stents market is increasing application of stents in gastrointestinal and glaucoma-related disorders. Rising incidence of urological problems, gastrointestinal diseases, glaucoma, and other conditions, are expected to increase the demand for non-vascular stents. For instance, in the U.S., gastrointestinal hemorrhage was the most common condition leading to hospitalization, with around 500,000 discharges recorded in 2012. Growing prevalence of gastrointestinal cancer is expected be a major factor driving growth of the global non-vascular stents market. Increasing respiratory and gastro-urological morbidities is increasing the demand for non-vascular stents, as these stents help maintain vessel patency. Furthermore, growing demand for minimally invasive procedures, which enable faster recovery, cause less pain, and involve shorter hospital stays, is expected to boost growth of the non-vascular stents market in the near future. Over the recent past, the demand for such stents is witnessing increasing in ophthalmic and neural applications. Both application areas—eyes and the brain—are sensitive to implantation of devices. Non-vascular stents, being a minimally invasive and accurate procedure, is rapidly being adopted for these applications. Smaller stents, known as a micro-stents, are being developed for application in areas related to eyes and the brain.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 35 market data tables and 25 figures on "Global Non-Vascular Stents Market - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to: